Body of work: Syndaver hires veteran CFO

The rapidly growing Tampa biotech firm accelerates toward an IPO.


  • By
  • | 6:00 a.m. September 7, 2018
  • | 0 Free Articles Remaining!
Terence Terenzi. Courtesy photo.
Terence Terenzi. Courtesy photo.
  • News
  • Share
Syndaver CEO Christopher Sakezles. Courtesy photo.
Syndaver CEO Christopher Sakezles. Courtesy photo.

Syndaver, a Tampa biotech firm that manufactures lifelike synthetic human and animal bodies for medical and veterinary training, has set its sights on an IPO in 2020. 

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

  • December 15, 2025
Lee Health CEO to step down

Sponsored Content